Pipeline

R&D is the core of our innovation. Sinotau has expanded product portfolio into oncology, cardiology and neurology with a diverse and competitive range of radiopharmaceutical pipelines. All with the mission of inventing radiopharmaceuticals for lives.

Diagnostic
Therapeutic

Cardiovascular disease

Pipeline
Pre-clinical
During clinical
NDA

XTR003

Myocardial viability assessment

XTR004

Myocardial perfusion imaging for detecting myocardial ischemia

Neurodegenerative disease

Pipeline
Pre-clinical
During clinical
NDA

XTR006

Alzheimer’s disease

Cancer

Pipeline
Pre-clinical
During clinical
NDA

XTR008

Neuroendocrine tumor

XTR009

Primary liver cancer

XTR010

Prostate cancer

XTR012

Prostate cancer

XTR015

Neuroendocrine tumor

XTR016

Solid tumor

XTR017

Solid tumor

XTR020

Prostate cancer